healtheo360 Wellness Blog

healtheo360 and VOI Collaborate to Create Global Cancer Information Network

Posted by healtheo360 on Dec 1, 2015 10:25:31 AM

NEW YORK and ENCINO, Calif., Dec. 1, 2015 /PRNewswire/ -- healtheo360®, a web portal for people living with chronic health conditions, and Vital Options International, a cancer communication, education and advocacy organization, today announced the launch of the Cancer Collaborative, a global information network providing live treatment news, policy updates, and support services to patients and caregivers via healtheo360's Internet, social media and broadcast channels.

Read Article

To Your Health: Antibiotic Resistance In America

Posted by healtheo360 on Oct 26, 2015 5:05:21 PM

Antibiotics are an important wonder-drug in the history of medicine. They can be life-savers but their misuse has far reaching and harmful effects in healthcare. One such chilling-effect is antibiotic resistance.

This quick guide shows how this affects you and also what you can do to help prevent antibiotic resistance.

Microbes in a petri- dish reacting to an antimicrobial agent (the dark spots) which keep can’t grow around the antibiotics
Read Article

Blood Cancer Awareness Month

Posted by healtheo360 on Sep 28, 2015 12:52:46 AM

Did you know that every 3 minutes someone in the US is diagnosed with blood cancer? The Leukemia & Lymphoma Society (LLS) is leading the way in funding research to advance breakthrough therapies and ensure access to treatments for blood cancers and improve the quality of life for patients and their families.

What is Blood cancer?

Read Article

Woman Says FedEx Lost Her Breast Cancer Sample

Posted by healtheo360 on Mar 28, 2014 10:17:20 AM

Justin Sullivan/Getty Images(NEW YORK) -- Marline Van Duyne almost underwent chemotherapy without knowing whether she was among the 80 percent of people with her type of breast cancer who don’t need it.

Read Article

Advanced Cervical Cancer: Trial Therapy Offers New Hope

Posted by healtheo360 on Mar 12, 2014 11:15:15 AM

Keith Brofsky/Thinkstock(RIO DE JANEIRO) -- Researchers have made great strides in early detection and prevention for cervical cancer, the third-most common cancer in women, including the HPV vaccine. But with all the progress, there are still thousands of women with advanced disease, and the five-year survival rate for late-stage cervical cancer is 15 percent. That number may now climb dramatically, if the results of a trial for Erlotinib, now in its second phase, proves typical.

The standard care for advanced cervical cancer is chemo-radiation and Cisplatin, a nonspecific drug. Erlotinib, the epidermal growth factor receptor (EGFR) inhibitor, is a type of biologic medication targeting growth receptors in the cancerous cells -- they can’t grow and cancer recedes.

For the study, which is published in the journal Cancer, Brazilian researchers at the Instituto de Cancer in Rio de Janeiro conducted a small trial in 36 women with Stage II and III cervical cancer (which now has a survival rate of 40 percent). After 77 weeks of treatment, all but two patients saw a complete disappearance of the cancer. At two and three years out, 92 percent and 80 percent of women survived, respectively.

Side effects of Erlotinib were generally manageable with patients experiencing mostly rashes and diarrhea.

According to the study authors, this is the first study to show that a target agent has promising activity against locally advanced cervical cancer. Still, more research is needed as the data presented in the trial is only preliminary.

Copyright 2014 ABC News Radio

Read Article

Elly Mayday: Plus-Sized Model Continues to Pose Despite Bald Head and Scars

Posted by healtheo360 on Feb 3, 2014 12:57:43 PM
Elly Mayday
Read Article

"The Little Couple" Star Jen Arnold Shares Chemo Photo

Posted by Team healtheo360 on Dec 29, 2013 9:32:26 AM

@JenArnoldMD/Twitter(HOUSTON) -- Just three weeks after she revealed she had a rare form of cancer, TV personality and neonatologist Jen Arnold has begun chemotherapy.

Read Article

Bone Tumor Drug for Dogs: Hope for Breast Cancer Patients?

Posted by healtheo360 on Nov 22, 2013 3:35:22 PM

Courtesy Penn Vet Center(PHILADELPHIA) -- Sasha, a 13-year-old American bulldog, was expected to die within months after losing her leg and undergoing chemotherapy for osteosarcoma, the same bone cancer that robbed Ted Kennedy Jr. of his leg in 1973 when he was 12.

Read Article

healtheo360 Wellness Blog

Information & Resources for Patients, Caregivers, Family and Friends

healtheo360 offers you content that is useful, digestible, and easy on the eyes. We update this blog regularly with infographics and artilces covering topics that matter to our community members. So read on, enjoy, and share!

Subscribe to Email Updates

Recent Posts

Posts by Topic

see all